Delivery Order SPE2DB22D1103-SPE2DB24FTFD2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $31,131.44 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This single-award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $94,370.39 Firm Fixed Price Delivery Order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $21,828.86, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to support federal government agencies. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award, valued at $7,216.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET in 30-count packages. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $36,315.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. The contract has an ultimate completion date of May 2, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award, with ID SPE2DX15D3016|SPE2DX22FBVR1, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $86,176.86 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a $45,749.97 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award provides for the delivery of BIKTARVY 50-200-25 MG TABLET (National Drug Code 61958-2201-1) in quantities of 30 tablets per package. The contract has an ultimate completion date of January 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,570.56, is for the delivery of BIKTARVY 50-200-25 MG TABLET (30s) and has a completion date of December 5, 2023. The parent company, Cencora, Inc., holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,177.10 firm fixed-price delivery order is for the supply of the medication Biktarvy, a 50-200-25 mg tablet, and has an ultimate completion date of December 7, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award, with ID SPE2DB20D3101 | SPE2DB23FRLZ7, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,728.40 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFD2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $21,451.77 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has no set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.5k | 2/12/24 |